{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:07:36Z","timestamp":1771657656846,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,15]]},"DOI":"10.7759\/cureus.37612","type":"journal-article","created":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T14:18:36Z","timestamp":1681568316000},"source":"Crossref","is-referenced-by-count":6,"title":["Development of High-Grade Sarcoma After Second Dose of Moderna Vaccine"],"prefix":"10.7759","author":[{"given":"Edward","family":"Bae","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suhwoo","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike","family":"Vays","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Abdelwahed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumar","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stewart","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00224-3","article-title":"Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study","volume":"21","author":"Menni C","year":"2021","unstructured":"Menni C, Klaser K, May A, et al.. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. Lancet Infect Dis. 2021, 21:939-49. 10.1016\/S1473-3099(21)00224-3","journal-title":"Lancet Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.40364","article-title":"Analysis of COVID-19 vaccine type and adverse effects following vaccination","volume":"4","author":"Beatty AL","year":"2021","unstructured":"Beatty AL, Peyser ND, Butcher XE, et al.. Analysis of COVID-19 vaccine type and adverse effects following vaccination. JAMA Netw Open. 2021, 4:e2140364. 10.1001\/jamanetworkopen.2021.40364","journal-title":"JAMA Netw Open"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-021-10087-9","article-title":"COVID-19 and myocarditis: a systematic review and overview of current challenges","volume":"27","author":"Castiello T","year":"2022","unstructured":"Castiello T, Georgiopoulos G, Finocchiaro G, et al.. COVID-19 and myocarditis: a systematic review and overview of current challenges. Heart Fail Rev. 2022, 27:251-61. 10.1007\/s10741-021-10087-9","journal-title":"Heart Fail Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher A","year":"2021","unstructured":"Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. 2021, 384:2092-101. 10.1056\/NEJMoa2104840","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1586\/era.09.76","article-title":"MFH classification: differentiating undifferentiated pleomorphic sarcoma in the 21st Century","volume":"9","author":"Matushansky I","year":"2009","unstructured":"Matushansky I, Charytonowicz E, Mills J, Siddiqi S, Hricik T, Cordon-Cardo C. MFH classification: differentiating undifferentiated pleomorphic sarcoma in the 21st Century. Expert Rev Anticancer Ther. 2009, 9:1135-44. 10.1586\/era.09.76","journal-title":"Expert Rev Anticancer Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.04.013","article-title":"Malignant fibrous histiocytoma: changing perceptions and management challenges","volume":"67","author":"Henderson MT","year":"2012","unstructured":"Henderson MT, Hollmig ST. Malignant fibrous histiocytoma: changing perceptions and management challenges. J Am Acad Dermatol. 2012, 67:1335-41. 10.1016\/j.jaad.2012.04.013","journal-title":"J Am Acad Dermatol"},{"key":"ref7","article-title":"Undifferentiated Pleomorphic Sarcoma","author":"Robles-Tenorio A","year":"2022","unstructured":"Robles-Tenorio A, Solis-Ledesma G. Undifferentiated Pleomorphic Sarcoma. StatPearls Publishing, Treasure Island, FL; 2022."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-021-01046-w","article-title":"COVID-19 vaccines for patients with cancer: benefits likely outweigh risks","volume":"14","author":"Hwang JK","year":"2021","unstructured":"Hwang JK, Zhang T, Wang AZ, Li Z. COVID-19 vaccines for patients with cancer: benefits likely outweigh risks. J Hematol Oncol. 2021, 14:38. 10.1186\/s13045-021-01046-w","journal-title":"J Hematol Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-014-2793-4","article-title":"Post-vaccination granulomas caused by delayed-type reaction to aluminum salts. (Article in German)","volume":"65","author":"Wahl RU","year":"2014","unstructured":"Wahl RU, Wurpts G, Merk HF. Post-vaccination granulomas caused by delayed-type reaction to aluminum salts. (Article in German). Hautarzt. 2014, 65:384-6. 10.1007\/s00105-014-2793-4","journal-title":"Hautarzt"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.radcr.2022.05.035","article-title":"COVID-19 vaccine-associated ganulomatous mass mimicking a sarcoma: a case report","volume":"17","author":"Quintero D","year":"2022","unstructured":"Quintero D, Patel N, Harris G, et al.. COVID-19 vaccine-associated ganulomatous mass mimicking a sarcoma: a case report. Radiol Case Rep. 2022, 17:2775-8. 10.1016\/j.radcr.2022.05.035","journal-title":"Radiol Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2147\/VMRR.S116556","article-title":"Vaccine-associated feline sarcoma: current perspectives","volume":"8","author":"Saba CF","year":"2017","unstructured":"Saba CF. Vaccine-associated feline sarcoma: current perspectives. Vet Med (Auckl). 2017, 8:13-20. 10.2147\/VMRR.S116556","journal-title":"Vet Med (Auckl)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/6952634","article-title":"Injection-site sarcoma in a dog: clinical and pathological findings","volume":"2017","author":"Jacobs TM","year":"2017","unstructured":"Jacobs TM, Poehlmann CE, Kiupel M. Injection-site sarcoma in a dog: clinical and pathological findings. Case Rep Vet Med. 2017, 2017:6952634. 10.1155\/2017\/6952634","journal-title":"Case Rep Vet Med"},{"key":"ref13","article-title":"Tuberous sclerosis complex","author":"Northrup H","year":"1993","unstructured":"Northrup H, Koenig MK, Pearson DA, Au KS. Tuberous sclerosis complex. GeneReviews\u00ae. Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A (ed): University of Washington, Seattle, WA; 1993."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-005-4756-2","article-title":"Renal angiomyolipoma with malignant transformation, simultaneous occurrence with malignity and other complex clinical situations","volume":"38","author":"Inci O","year":"2006","unstructured":"Inci O, Kaplan M, Yalcin O, Atakan IH, Kubat H. Renal angiomyolipoma with malignant transformation, simultaneous occurrence with malignity and other complex clinical situations. Int Urol Nephrol. 2006, 38:417-26. 10.1007\/s11255-005-4756-2","journal-title":"Int Urol Nephrol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004371","article-title":"Spontaneous tumor regression following COVID-19 vaccination","volume":"10","author":"Sousa LG","year":"2022","unstructured":"Sousa LG, McGrail DJ, Li K, et al.. Spontaneous tumor regression following COVID-19 vaccination. J Immunother Cancer. 2022, 10:e004371. 10.1136\/jitc-2021-004371","journal-title":"J Immunother Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/147360-development-of-high-grade-sarcoma-after-second-dose-of-moderna-vaccine","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:59:04Z","timestamp":1707508744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/147360-development-of-high-grade-sarcoma-after-second-dose-of-moderna-vaccine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,15]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.37612","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,15]]}}}